These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 30891627)

  • 1. The pathogenicity of Th17 cells in autoimmune diseases.
    Yasuda K; Takeuchi Y; Hirota K
    Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
    van Hamburg JP; Tas SW
    J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells in immunity and autoimmunity.
    Bedoya SK; Lam B; Lau K; Larkin J
    Clin Dev Immunol; 2013; 2013():986789. PubMed ID: 24454481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
    Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
    J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases.
    Huang J; Xu X; Yang J
    Front Immunol; 2021; 12():593473. PubMed ID: 33968012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cell pathogenicity and plasticity in rheumatoid arthritis.
    Yang P; Qian FY; Zhang MF; Xu AL; Wang X; Jiang BP; Zhou LL
    J Leukoc Biol; 2019 Dec; 106(6):1233-1240. PubMed ID: 31497905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.
    Burkett PR; Meyer zu Horste G; Kuchroo VK
    J Clin Invest; 2015 Jun; 125(6):2211-9. PubMed ID: 25961452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity.
    Chen Y; Chauhan SK; Tan X; Dana R
    J Autoimmun; 2017 Feb; 77():96-103. PubMed ID: 27899224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies.
    Zhao J; Lu Q; Liu Y; Shi Z; Hu L; Zeng Z; Tu Y; Xiao Z; Xu Q
    J Immunol Res; 2021; 2021():8816041. PubMed ID: 33553436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    Stadhouders R; Lubberts E; Hendriks RW
    J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases.
    Wu X; Tian J; Wang S
    Front Immunol; 2018; 9():1112. PubMed ID: 29892286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo.
    Banerjee D; Zhao L; Wu L; Palanichamy A; Ergun A; Peng L; Quigley C; Hamann S; Dunstan R; Cullen P; Allaire N; Guertin K; Wang T; Chao J; Loh C; Fontenot JD
    Immunology; 2016 Apr; 147(4):399-413. PubMed ID: 26694902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis.
    Ulivieri C; Baldari CT
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IL-17F is associated with non-pathogenic Th17 cells.
    Wanke F; Tang Y; Gronke K; Klebow S; Moos S; Hauptmann J; Shanmugavadivu A; Regen T; Mufazalov IA; Gabriel LA; Reißig S; Diefenbach A; Kurschus FC; Waisman A
    J Mol Med (Berl); 2018 Aug; 96(8):819-829. PubMed ID: 29959474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.
    Raveney BJ; Oki S; Yamamura T
    PLoS One; 2013; 8(2):e56595. PubMed ID: 23437182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q10 suppresses Th17 cells and osteoclast differentiation and ameliorates experimental autoimmune arthritis mice.
    Jhun J; Lee SH; Byun JK; Jeong JH; Kim EK; Lee J; Jung YO; Shin D; Park SH; Cho ML
    Immunol Lett; 2015 Aug; 166(2):92-102. PubMed ID: 26045320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected targets and triggers of autoimmunity.
    Lee Y; Collins M; Kuchroo VK
    J Clin Immunol; 2014 Jul; 34 Suppl 1(0 1):S56-60. PubMed ID: 24789684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.